Ionis Pharmaceuticals

Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
AstraZeneca stays on course to challenge Alnylam with 66-week rare disease data
Fierce Biotech
Mon, 03/27/23 - 10:22 am
AstraZeneca
Ionis Pharmaceuticals
aplontersen
Alnylam
Onpattro
clinical trials
ATTRv-PN
Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement
Investors Business Daily
Thu, 03/23/23 - 09:58 am
Ionis Pharmaceuticals
Biogen
ALS
FDA
tofersen
Neurofilament as a surrogate endpoint goes on trial in tofersen adcomm
BioSpace
Mon, 03/20/23 - 11:40 am
ALS
Biogen
Ionis Pharmaceuticals
FDA
tofersen
clinical trials
Ionis announces FDA acceptance of New Drug Application for eplontersen for the treatment of hereditary transthyretin-mediated amyloid polyneuropathy
PR Newswire
Wed, 03/8/23 - 09:47 am
Ionis Pharmaceuticals
FDA
eplontersen
hATTR-pn
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
Biogen/ Ionis ALS therapy set for March FDA AdCom meeting
Seeking Alpha
Mon, 01/23/23 - 11:12 am
Biogen
Ionis Pharmaceuticals
FDA
ALS
tofersen
JPM23: Ionis CEO admits PCSK9 ship captained by Big Pharmas may have sailed
Fierce Biotech
Wed, 01/11/23 - 11:02 pm
Ionis Pharmaceuticals
AstraZeneca
ION449
Ionis gets into gene editing
EP Vantage
Mon, 11/14/22 - 10:39 am
Ionis Pharmaceuticals
gene editing
Metagenomi
Ionis presents positive Phase 2 data from open label extension study of donidalorsen at 2022 ACAAI Annual Meeting
Yahoo Finance
Sun, 11/13/22 - 06:59 pm
Ionis Pharmaceuticals
clinical trials
donidalorsen
hereditary angiodema
HAE
As Roche prepares to take a kidney disease drug into PhIII, Ionis fleshes out the data
Endpoints
Mon, 11/7/22 - 05:24 pm
Roche
Ionis Pharmaceuticals
IONIS-FB-LRx
kidney disease
Ionis to build new manufacturing site in Southern California, doubling the size of its current site
Endpoints
Thu, 10/13/22 - 11:55 pm
Ionis Pharmaceuticals
drug manufacturing
California
PCSK9 pipeline shows signs of saturation
EP Vantage
Tue, 09/27/22 - 10:21 am
AstraZeneca
ION449
Ionis Pharmaceuticals
Novartis
Leqvio
PCSK9 inhibitors
AstraZeneca dumps Ionis drug despite hit in phase 2 cholesterol trial
Fierce Biotech
Fri, 09/23/22 - 11:00 am
AstraZeneca
Ionis Pharmaceuticals
clinical trials
ION449
cholesterol
Data drip sheds little light on how Ionis, AstraZeneca compare to Alnylam in rare disease
Fierce Biotech
Wed, 09/7/22 - 10:18 am
AstraZeneca
Ionis Pharmaceuticals
Alnylam
antisense
ATTRv-PN
aplontersen
Bayer-Ionis' anti-thrombotic med doesn't increase bleeding in phase 2, setting stage for a new type of anticoagulant
Fierce Biotech
Thu, 07/28/22 - 05:54 pm
Bayer
Ionis Pharmaceuticals
kidney disease
clinical trials
fesomersen
Ionis announces enrollment completion of Phase 3 Lp(a) HORIZON cardiovascular outcomes study of pelacarsen
Yahoo Finance
Wed, 07/20/22 - 09:31 am
Ionis Pharmaceuticals
clinical trials
cardiovascular disease
pelacarsen
Ionis hands off an antisense drug for kidney disease, giving all rights to Roche
Endpoints
Mon, 07/11/22 - 06:23 pm
Ionis Pharmaceuticals
Roche
IONIS-FB-LRx
clinical trials
immunoglobin A nephropathy
kidney disease
After phase 3 fail, Biogen posts 12-month data cut to make case for ALS prospect
Fierce Biotech
Fri, 06/3/22 - 09:16 am
Biogen
Ionis Pharmaceuticals
ALS
clinical trials
antisense
SOD1-ALS
Ionis, AstraZeneca change a key trial, fueling more questions about a genetic heart disease
BioPharma Dive
Mon, 05/2/22 - 11:03 am
Ionis Pharmaceuticals
AstraZeneca
clinical trials
transthyretin amyloid cardiomyopathy

Pages